Trial intelligence / Profile preview

TIVA vs Sevoflurane in Laparoscopic Colorectal Cancer Surgery

NCT04239794Active, not recruiting

Sponsor
Seoul National University Hospital
Start
Feb 2020
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of propofol injection (veterinary) in colorectal cancer (CRC) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Postoperative 24 h opioid consumption. Started Feb 2020; status: active, not recruiting.

02

Drugs

propofol injection (veterinary)
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT04239794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04239794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call